Original ResearchPublished 8 October 2026Evaluation of the anticancer effects of kaempferol using in vitro assays and [ 99m Tc]Tc-PSMA SPECT/CT imaging in a DMBA-induced breast cancer modelFatma J. Al-SaeediFrontiers in Pharmacologydoi 10.3389/fphar.2026.1961418
Original ResearchPublished 7 September 2026Bridging to systemic therapy: PSMA-PET-based early and repetitive stereotactic body radiotherapy for nodal and bone oligo-recurrent prostate cancerArne Grün · Alexandra Partyka · Markus Galler · Torsten Schlomm · Dirk Böhmer · Kurt Miller · Daniel Zips · Goda KalinauskaiteFrontiers in Urologydoi 10.3389/fruro.2026.1738508
ReviewPublished 27 August 2026Artificial intelligence across oncologic theranostics: evidence for patient stratification, dosimetry, and adaptive radiopharmaceutical therapyMallareddy Banala · Shabbir Ezuddin · Mark Foley · Russ KukerFrontiers in Nuclear Medicinedoi 10.3389/fnume.2026.1935247
Original ResearchPublished 14 August 2026Gap junction protein connexin 36 proteostatic mechanisms in photoreceptor cells subjected to excitotoxic stressMonika Katan · Klaudia Mróz · Joanna Lewin-Kowalik · Adrian SmędowskiActa Biochimica Polonicadoi 10.3389/abp.2026.160914,342 views
ReviewPublished 31 July 2026Circulating tumour DNA in mCRPC: bridging tumour biology and real-time treatment monitoringChimbabantu Kaoma · Mike Sathekge · Joseph Chalwe · Kgomotso Mokoala · Mankgopo KgatleFrontiers in Molecular Medicinedoi 10.3389/fmmed.2026.1852641
Original ResearchPublished 29 July 2026MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancerMichael Courtney · Robert Whiriskey · Ciaran Johnston · Niall SheehyFrontiers in Nuclear Medicinedoi 10.3389/fnume.2026.1854064
ReviewPublished 15 July 2026PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencingNatalia Gierulska · Nina Jankowska · Adrianna Kwiatkowska · Piotr Kuchno · Kinga Łysak · Katarzyna Szklener · Kamil Kośmider · Magdalena SkórzewskaOncology Reviewsdoi 10.3389/or.2026.1834484
ReviewPublished 4 June 2026Availability, accessibility, and economic feasibility of radionuclide therapies in Africa: a systematic review and quantitative infrastructure analysisEfrah Ahmed IbrahimFrontiers in Nuclear Medicinedoi 10.3389/fnume.2026.1825650
ReviewPublished 29 May 2026Next-generation imaging in prostate cancerAhmed Rabie · Maurizio Buscarini · Osama ZaytounFrontiers in Urologydoi 10.3389/fruro.2026.1829407
Case ReportPublished 10 March 2026Incidental detection of PDAC via 18 F-PSMA PET/CT in a patient with recurrent prostate cancer. A case reportGiordano Savelli · Mattia Bonacina · Alberto Soffientini · Elvira Archiati · Claudio Bnà · Alberto ZaniboniFrontiers in Nuclear Medicinedoi 10.3389/fnume.2026.1767321
CorrectionPublished 12 December 2025Correction: Comparative dosimetric evaluation of 68Ga-PSMA and 18F-Choline PET/CT imaging in prostate cancer: implications for radiation safety and SUVmax correlationHussein R. Kaafarani · Mohamad Haidar · Hanna El-BalaaFrontiers in Nuclear Medicinedoi 10.3389/fnume.2025.1760153
Original ResearchPublished 1 December 2025Comparative dosimetric evaluation of 68Ga-PSMA and 18F-Choline PET/CT imaging in prostate cancer: implications for radiation safety and SUVmax correlationHussein R. Kaafarani · Mohamad Haidar · Hanna El-BalaaFrontiers in Nuclear Medicinedoi 10.3389/fnume.2025.1702390
Nuclear MedicinePublished 23 October 2025PET/CT imaging of bone disorders in dysparathyroidism: a comprehensive reviewE. Panagiotidis · G. Angelidis · V. Valotassiou · I. Tsougos · P. Georgoulias · J. T. Zhang-YinFrontiers in Nuclear Medicinedoi 10.3389/fnume.2025.1645497
